Global Pterygium Drug Market - Industry Trends and Forecast to 2029

Segmentation

Short Description
Global Pterygium Drug Market, By Type (Progressive Pterygium and Atrophic Pterygium), Stages (Stage 2, Stage 3, Stage 1, Stage 4), Treatment (Artificial Tears/Topical Lubricants and Steroid Eye Drops.), Formulation (Eye Drops, Eye Ointments, Others), Mode of Purchase (Prescription and Over the Counter (OTC)), Population Type (Geriatric and Adults), End-User (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Region (North America, Europe, Asia-Pacific, South America, Middle East, and Africa) Industry Trends and Forecast to 2029
Market Definition:

Pterygium is a common ocular surface lesion that begins in the limbal conjunctiva within the palpebral fissure and progresses to the cornea. It is named after the Greek word pterygos, which means "wing". The lesion occurs more frequently at the nasal limbus than the temporal with a characteristic wing-like appearance. UV exposure is strongly linked to the occurrence of pterygia. Individuals having a history of elevated UV exposure and those living closer to the equator have a higher incidence (outdoor work). According to certain research, males have a somewhat higher incidence than females, which could be due to a higher rate of UV exposure.
It can cause redness, inflammation, and a change in the look of the eye; it can create astigmatism, which can cause blurry vision; and it can cause a whitish or pinkish growth covering the front of the eye. It could affect one or both eyes.
Pterygium is diagnosed using a microscope to examine the front components of the eye during a full eye examination and based on the appearance of tissue growth on the cornea from the white area of the eye.
Market Segmentation:
The global pterygium drug market is categorized into eight segments: disease type, stages, treatment, formulation, mode of purchase, population type, end-user, and distribution channel.
 On the basis of disease type, the global pterygium drug market is segmented into progressive pterygium and atrophic pterygium
 On the basis of stages, the global pterygium drug market is segmented into stage 2, stage 3, stage 1, and stage 4
 On the basis of treatment, the global pterygium drug market is segmented into artificial tears/topical lubricants and steroid eye drops
 On the basis of formulation, the global pterygium drug market is segmented into eye drops, eye ointments, and others
 On the basis of mode of purchase, the global pterygium drug market is segmented into prescription and over-the-counter (OTC)
 On the basis of population type, the global pterygium drug market is segmented into geriatric and adults
 On the basis of end-user, the global pterygium drug market is segmented into hospitals, specialty clinics, home healthcare, and others
 On the basis of distribution channel, the global pterygium drug market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others

Market Players

Some of the major players operating in the global pterygium drug market are:

 Johnson & Johnson Services, Inc.
 Novartis AG
 Akorn Operating Company LLC
 Bausch & Lomb Incorporated
 AbbVie Inc.
 Prestige Consumer Healthcare Inc.
 Spectra Vision Care,
 Tha Laboratories
 Wellona Pharma
 SAGER PHARMA
 Maya Biotech Private Limited 
 EYERIS VISIONCARE Pvt. Ltd.
 Sylentis
 Bayer AG
 Zydus Group
 Amneal Pharmaceuticals LLC
 OASIS Medical
 Similasan Corporation
 Alcon
 Santen Pharmaceutical Co.

Methodology